MJardin Group, Inc. (MJARF)
MJardin Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $90,140. Its beta of 0.62 implies it has historically moved less than the broad market.
MJardin Group Inc. is a company actively involved in the cultivation, harvesting, processing, and sale of cannabis products throughout Canada and the United States. Beyond its own product lines, MJardin extends its expertise by offering a comprehensive suite of consulting and advisory services to other licensed cannabis operators, specifically those engaged in cultivation and retail. This support covers a broad spectrum, including strategic capital and financing, project management for cultivation facilities, assistance with licensure, facility design, system implementation, property and equipment leasing, construction oversight, and the critical operational ramp-up phase. The company also provides access to its proprietary intellectual property. MJardin's influence spans a portfolio of 32 cannabis operations, which it either owns, manages, or provides guidance for. Established in 2014, the company maintains its headquarters in Ontario, Canada.